UCLA researchers examining outcomes for advanced heart-failure patients over the past two decades have found that, coinciding with the increased availability and use of new therapies, overall mortality has decreased and sudden cardiac death, caused by the rapid onset of severe abnormal heart rhythms, has declined.

In an age when microbial pathogens are growing increasingly resistant to the conventional antibiotics used to tamp down infection, a team of Wisconsin scientists has synthesized a potent new class of compounds capable of curbing the bacteria that cause staph infections.

UAlberta medical researchers discover new ways to target, develop and design drugs to prevent and treat viral infection.

Computational model offers insight into mechanisms of drug-coated balloons. - Over the past few decades, scientists have developed many devices that can reopen clogged arteries, including angioplasty balloons and metallic stents.

MINNEAPOLIS / ST. PAUL (05/16/2013) —Informed consent is the backbone of patient care.

Cardiac study used as source for new guidelines on treating people undergoing coronary artery bypass surgery.

Until now, little was scientifically known about the human potential to cultivate compassion — the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.

When infections occur in the body, stem cells in the blood often jump into action by multiplying and differentiating into mature immune cells that can fight off illness.

ANN ARBOR-Whooping cough has exploded in the United States and some other developed countries in recent decades, and many experts suspect ineffective childhood vaccines for the alarming resurgence.

Cholesterol testing fails to accurately predict high risk of heart attack in patients with kidney disease, UAlberta research shows.